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26S proteasomeUncoupling protein 3 (UCP3) is implicated in mild uncoupling and the regulation of mitochondrial ROS
production. We previously showed that UCP3 turns over rapidly in C2C12 myoblasts, with a half-life of 0.5–4 h,
and that turnover can be reconstituted in vitro. We show here that rapid degradation of UCP3 in vitro in isolated
brown adipose tissue mitochondria required the 26S proteasome, ubiquitin, ATP, succinate to generate a high
membrane potential, and a pH of 7.4 or less. Ubiquitin containing lysine-48 was both necessary and sufﬁcient to
support UCP3 degradation, implying a requirement for polyubiquitylation at this residue. The 20S proteasome
did not support degradation. UCP3 degradation was prevented by simultaneously blocking matrix ATP
generation and import, showing that ATP in the mitochondrial matrix was required. Degradation did not appear
to require a transmembrane pH gradient, but was very sensitive to membrane potential: degradation was halved
when membrane potential decreased 10–20 mV from its resting value, and was not signiﬁcant below about
120 mV. We propose that matrix ATP and a high membrane potential are needed for UCP3 to be
polyubiquitylated through lysine-48 of ubiquitin and exported to the cytosolic 26S proteasome, where it is
de-ubiquitylated and degraded.enine nucleotide translocase;
ctylate
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The uncoupling proteins, UCP1, UCP2 and UCP3, are closely-related
members of the mitochondrial anion carrier family, integral membrane
proteins that transport metabolic substrates and ions across the
mitochondrial inner membrane [1]. The crystal structure is known for
one member, the adenine nucleotide translocase (ANT); it has six
transmembrane helices and its N- and C-termini extend into the
intermembrane space [2]. The primary sequences of other members of
the family, including the UCPs, ﬁt comfortably into this ANT
structure [3].
UCP1 mediates adaptive thermogenesis in brown adipose tissue.
By regulated protonophoric action it lowers the protonmotive force
that drives oxidative phosphorylation and so stimulates respiration
and heat production [4]. UCP2 protein is found in kidney, pancreas,
lung, immune cells, and brain [5,6], while UCP3 is mainly restricted to
skeletal muscle and brown adipose tissue [5]. Though multiple
functions for UCP2 and UCP3 have been proposed, there is good
evidence that they attenuate production of reactive oxygen species by
partially dissipating protonmotive force [6].
UCP2 and UCP3 proteins are degraded rapidly in cells, with half-
lives of b4 h, and this degradation can be prevented by proteasomeinhibitors [7–9]. In contrast, the closely-related UCP1 and ANT display
turnover rates of 1–5 days [10,11], consistent with general mitophagy
[10]. Rapid degradation combined with tight transcriptional and
translational control allows dynamic regulation of UCP2 protein levels
in response to physiological changes [12], implying that protein level
is an important control over the activity of these proteins.
Rapid degradation of both UCP2 [8] and UCP3 [9] can be
reconstituted in vitro by incubation of isolated, energized mitochondria
with puriﬁed 26S proteasome and components of the ubiquitylation
machinery. Degradation of UCP2 requires the 26S proteasome, ATP,
succinate, and protonmotive force [8], leading to a model in which
energized mitochondria facilitate the translocation and 26S-targeted
degradationofUCP2.DegradationofUCP3 is lesswell-characterized, but
is known to require the26Sproteasome [9] and is presumed to share the
same degradation pathway as UCP2.
In the present paper we characterize the molecular components
and biochemical conditions required for degradation of UCP3 in vitro.
We show that it requires K48-linked polyubiquitylation and matrix
ATP, and is very sensitive to small decreases in mitochondrial
membrane potential.
2. Materials and methods
2.1. Animals
FemaleWistar rats (Harlan Laboratories) were housed at 22±2 °C,
45±15% humidity, 12/12 h light/dark cycle, with standard chow and
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following sacriﬁce by CO2 asphyxia and cervical dislocation. All animal
experiments were carried out following standards and guidelines of
the American Veterinary Medical Association and the Association for
the Assessment and Accreditation of Laboratory Animal Care and
approved by the Buck Institute Institutional Animal Care and Use
Committee (protocol number 10080).B
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Brown adipose tissue mitochondria were isolated as previously
described [9]. Brieﬂy, brown adipose tissue from 1–4 animals was
collected into buffer A (250 mM sucrose, 10 mM TES, 1 mM EDTA and
1% w/v defatted BSA) on ice and tissue was chopped then
disaggregated using a Dounce homogenizer. The homogenate was
ﬁltered through two layers of gauze and centrifuged at 8500 g for
10 min. The pellet was gently resuspended in buffer B (250 mM
sucrose, 20 mMTES, 1 mMEGTA and 0.4%w/v BSA) and centrifuged at
700 g for 10 min. The supernatant was centrifuged at 8500 g for
10 min, and the ﬁnal pellet was resuspended in buffer B. Protein
concentrations were determined using the biuret method.D
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ANT2.3. In vitro degradation assay
Isolated mitochondria were incubated with 26S proteasome (Enzo
Life Sciences, #PW9310), ubiquitin (Boston Biochem #U-100) and
partially puriﬁed E1-E3 ligase fractions (Boston Biochem, catalogue
number K-960, or Calbiochem, catalogue number 662096), succinate,
and an ATP-regenerating system as previously described [9]. The initial
reconstitution system (250 μL total volume) contained 1 mg/mL brown
adipose tissuemitochondria, 1 mMATP, 10 mMphosphocreatine, 20 U/
mL creatine kinase, ubiquitylation fractions (1.6 μg Fraction 1 and 1.6 μg
Fraction 2), 120 μM puriﬁed ubiquitin, 12 μg/mL 26S proteasome, and
20 mMsuccinate. This mediumwas used for Figs. 1 and 2, but the ligase
fractions were omitted in Figs. 3–7 as Fig. 2 demonstrates their
dispensability. Experiments were carried out at 37 °C in a modiﬁed
hypotonic potassium-HEPES medium (50 mMKCl, 5 mMHEPES, 1 mM
EGTA, 4 mMKH2PO4, and 5 mMMgCl2, pH 7.2 except where noted), or,
where indicated in Fig. 1, in a high-sucrose medium [9] comprising
250 mM sucrose, 5 mMTris–HCl, and 2 mMEGTA, pH 7.4. As a negative
control, mitochondria were incubated with all components except 26S
proteasome. After different incubation times, reaction was stopped by
pelletingmitochondria and resuspending in1×Laemmli protein loading
buffer (50 mMTris–HCl, 10% v/v glycerol, 2% SDS, 1 mMEDTA, 1% v/vβ-
mercaptoethanol, and 0.01% w/v bromophenol blue, pH 6.8) supple-
mented with complete protease inhibitor (Roche) and 25 mM N-
ethylmaleimide. UCP3 levels were subsequently assayed by Western
blot.Total protein (µg) Total protein (µg)
B
Time (min)
E
Ba
nd
 in
te
ns
ity
 (a
u)
Total protein (µg)
25
20
15
10
5
Fig. 1. In vitro reconstitution of UCP3 degradation in mitochondria isolated from brown
adipose tissue. (A) Brown adipose tissue mitochondria were incubated in high-sucrose
(STE) (circles) or hypotonic potassium-HEPES (KHE) medium (diamonds) containing
all reconstitution components (+, ﬁlled symbols) or lacking only the 26S proteasome
(−, open symbols) (Section 2.3). Reaction was stopped at the times shown and the
samples were assayed by Western blot. All data are normalized ﬁrst to UCP1 in the
same lane and then to the appropriate zero timepoint, and represent means±SEM
(n=6 independent experiments). (B) Representative immunoblot of mean intensity.
Proteins (5 μg of protein/lane) were separated by SDS/PAGE and immunoblotted for
UCP3 and reblotted for UCP1 and ANT. (C) Statistical signiﬁcance was determined by
calculating the area under the curve and performing one-way ANOVA on the resulting
values. ctl, control lacking 26S proteasome. Data represent individual values with
means±SEM. (D) Intensity of signals obtained by Western blot for UCP3, UCP1, and
ANT for different loadings of total mitochondrial protein. Data represent means±SEM
(n=3–4). (E) Quantiﬁcation of the signal intensity of UCP1 (circles) and ANT (squares)
during incubation under degradation conditions (KHE, reconstitution components, 26S
proteasome). Raw band intensity was normalized to total protein loaded (n=11).
Fig. 2. Components required for UCP3 degradation in vitro.Degradation of UCP3 in brown
adipose tissue mitochondria in 12 variants of the in vitro assay in the presence (+) or
absence (blank) of the components indicated. Bars represent Western blot intensities at
240 min incubation relative to time zero. Values are means±SEM (n=8–9 independent
experiments). BAT, mitochondria isolated from brown adipose tissue; 26S, puriﬁed 26S
proteasome; Suc, succinate; Ub, puriﬁed ubiquitin; F1, partially puriﬁed cellular fraction
containing E1-E2 ligases; F2, partially puriﬁed cellular fraction containing E3 ligases and
de-ubiquitylases.
Fig. 3. Ubiquitin mutants alter UCP3 degradation in vitro. (A) Degradation of UCP3 in
brown adipose tissue mitochondria in vitro in the presence of different puriﬁed mutant
ubiquitins (Boston Biochem UM-K48R, UM-K48O, U-501). Symbols: no 26S (open
circles): all required in vitro components, including wild-type ubiquitin, minus the 26S
proteasome. Ub (closed circles): wild-type ubiquitin. Ub-K48R (open diamonds)
contains a Lys-Arg substitution at position 48, disrupting polymerization. Ub-K48O
(closed diamonds) retains Lys48, while the six remaining Lys residues are substituted
with Arg. Ub-Ch4 (closed inverted triangles) is methylated at the terminal amines of all
Lys residues, blocking polymerization. No Ub (open inverted triangles) no added
ubiquitin. (B) Area under the curve values of the individual experiments in (A). Data in
(A) and (B) depict means±SEM (n=4–7).
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Samples (5 μg mitochondrial protein) were resolved by 10% SDS-
polyacrylamide gel electrophoresis and transferred to nitrocellulose
membranes (Amersham Biosciences). Western blot analysis was
performed with the indicated primary antibodies (UCP3: PA1-044,
Thermo; UCP1:U6382, Sigma; ANT: sc-9300, Santa Cruz Biotechnology)
overnight at 4 °C and appropriate secondary antibodies (31463,
Pierce) for 1 h at ~20 °C. Protein was visualized with enhanced
chemiluminescence (Amersham) and X-ray ﬁlm. For stripping and re-
probing, blotswere incubatedwithRestore StrippingBuffer (Pierce) and
washed in 1× TBST (20 mMTris–HCl, 137 mMNaCl, and 0.1% Tween 20,
pH 7.6) prior to re-probing with additional primary antibody.
2.5. Proteasome activity
Chymotrypsin-like peptidase activities of the 20S (Boston Biochem)
and 26S (Enzo) proteasomes were measured using the ﬂuorogenic
substrate Suc-LLVY-amc (S-280, Boston Biochem). Proteasome was
incubatedwith 50 μMsubstrate in degradation assay buffer (above) and
samples were read on a Molecular Devices microplate reader at em–ex
380–460 using SoftMax Pro software. Fluorescence was calibrated to
free aminomethylcoumarin to give activity in pmol substrate/min/μg
protein.
2.6. Mitochondrial membrane potential
Mitochondrial membrane potential was measured using a tri-
phenylmethyl phosphonium (TPMP+)-sensitive electrode in an
oxygen electrode chamber (Rank Bros, UK) monitored by a Powerlab
4/20 (AD Instruments) and analyzed with Powerlab Chart software
[13]. Brown adipose tissue mitochondria (0.35 mg protein/mL) were
incubated in hypotonic potassium-HEPES medium as above, with the
addition of 5 μM rotenone, 0.1 μM nigericin, 1 μg/mL oligomycin, and
2 μM TPMP. To mimic the in vitro degradation assay, ubiquitin,
succinate, and the ATP regenerating system components were added.
To titrate membrane potential in Fig. 5A–C, different ratios of
succinate andmalonate were added to a combined ﬁnal concentration
of 20 mM. For Fig. 5D, 20 mM succinate was added to an incubationcontaining nigericin, oligomycin and TPMP as above, and aliquots
were placed in the TPMP electrode chamber at the times shown and
the signal was recorded. After depolarization by addition of 30 μM
FCCP, four further additions of 0.5 μM TPMP were made, allowing
back-calibration of the TPMP signal. For consistency, the experiment
in Fig. 5A was calibrated in the same way. This departure from the
standard calibration [13] caused an underestimation of membrane
potential by 15–20 mV.2.7. Cytochrome c release
Isolated mitochondria (1 mg protein) were incubated under the
degradation assay conditions in 1 mL of hypotonic potassium-HEPES
buffer as described in Section 2.3. At each time point, samples were
centrifuged at 10,000 × g for 10 min. The resulting supernatant was
removed and frozen for subsequent analysis. Cytochrome c levels were
determined by measuring the 414 nm peak of non-reduced samples
using a dual-beam spectrophotometer zeroed with incubation buffer.
Total cytochrome c levels were determined by addition of 0.5% w/v
sodium deoxycholate to the incubated samples, permeabilizing mito-
chondria prior to centrifugation.
Fig. 4. Effects of bioenergetic inhibitors and ionophores on UCP3 degradation in vitro.
Degradation of UCP3 in brown adipose tissue mitochondria in vitro in the presence of
(A) 1 μg/mL oligomycin (oli), 2.5 μM carboxyatractylate (CAT), or both, or (B) 0.1 μM
nigericin (nig) or 0.5 μM valinomycin (val). Symbols:−26S (open circles): all required in
vitro components minus the 26S proteasome. 26S (closed circles): all required in vitro
components, including26Sproteasome. CAT: closed diamonds.Oli closed inverted triangles.
Oli+CAT: triangles. Nig: closed squares. Val: “x” symbols. (C)Area under thecurvevalues of
the individual experiments in (A) and (B). Data represent means±SEM (n=4–6).
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UCP3 degradation was monitored by quantitative Western blot.
Blots were scanned to generate digital images and analyzed using NIH
ImageJ software. All UCP3 band intensities were normalized to UCP1before further analysis. The resulting degradation proﬁles were used
to calculate area under the curve values using trapezoidal curve ﬁtting
with a cutoff at 0.5. Statistical analysis was performed using repeated-
measures ANOVA against negative control conditions followed by
Dunnet's post-hoc testing. *pb0.05; **pb0.01; ***pb0.005. Where
appropriate, one-phase decay curves were ﬁtted to degradation
proﬁles as trend lines and to allow crude estimation of half-lives.
Such curve ﬁts likely overestimate the true half-life, as decreases in
membrane potential during the incubation (Fig. 5) slow degradation,
invalidating an assumption of one-phase decay for the total
incubation period. However, one-phase decay curves clarify the
plotted data, and so are included here. To determine statistical
differences between treatments, values of area under the curve were
preferred, to minimize assumptions about the type of curve. Where
shown, representative blot images were chosen for best visual ﬁt to
the mean values plotted after normalization to UCP1 as a protein
loading control.
3. Results
3.1. UCP3 degradation in vitro
UCP3 degradation in vitro was previously investigated in a high-
sucrose medium. It is possible that the resulting condensation of
mitochondrial cristae alters UCP3 degradation [9]. For the present
studies, we used a hypo-osmotic potassium-based medium designed
to optimize the respiratory activity of brown adipose tissue
mitochondria by expanding the cristae [14]. UCP3 degradation was
similar in the two buffers (Fig. 1A), showing that the UCP3
degradation mechanism is largely unaffected by osmotic and other
differences between the twomedia. Fig. 1A and B show that UCP3was
degraded only in the presence of the 26S proteasome, while Fig. 1B
and E demonstrate that UCP1 and ANT were not similarly degraded,
conﬁrming previous results [9]. Fig. 1C shows the statistical analysis of
the data in Fig. 1A. In the total protein range loaded per well, (5 μg
protein), the band intensities for UCP3, UCP1, and ANT were
dependent on total protein loaded (Fig. 1D), validating the use of
signal intensity to quantify relative protein levels. UCP1 and ANT
levels remained constant as a function of time during the degradation
assay (Fig. 1E).
3.2. Requirements for UCP3 degradation in vitro
Rapid degradation of UCP2 in intact cells requires the membrane
potential component of the protonmotive force, and is prevented by
proteasome inhibitors [8]. Degradation of UCP2 in vitro requires
addition of succinate and the 26S proteasome, and the presence of
protonmotive force [8]. We have previously shown that UCP3
degradation in cells is also rapid and prevented by proteasome
inhibition [9], and that degradation of UCP3 in vitro in the presence of
a cocktail of ingredients that supports degradation of UCP2 requires
the 26S proteasome ([8], Fig. 1B), but otherwise nothing is known
about the requirements for turnover of UCP3.
To determine the components required for UCP3 degradation in
isolatedmitochondria in vitro, we added theminimal components of an
ATP regenerating system (needed to support proteasome activity), and
the 26S proteasome. We then tested different additions of succinate,
puriﬁed ubiquitin, and partially characterized ubiquitin E1/E2 (Fraction
1) and E3/de-ubiquitylase (Fraction 2) ligase fractions. Only assays
containing both succinate and ubiquitin supported degradation of UCP3
(Fig. 2). The requirement for succinate presumably reﬂects the
requirement for protonmotive force (see Section 3.6, Fig. 5). Further
addition of the ubiquitin ligase fractions did not enhance degradation,
showing that these components are dispensable in vitro and suggesting
that the ubiquitin ligase machinery that is presumably needed for UCP3
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Fig. 5. Effect of mitochondrial membrane potential on UCP3 degradation in vitro. Isolated brown adipose tissue mitochondria incubated under degradation assay conditions (all
required components minus 26S proteasome) with the addition of nigericin and oligomycin, which do not alter UCP3 degradation kinetics (Fig. 4). (A) Membrane potential of
isolated brown adipose tissue mitochondria approximately 3 min after substrate addition, incubated under degradation assay conditions at different malonate concentrations
(combined succinate plus malonate kept at 20 mM). Data represent means±SEM (n=3). (B) Degradation of UCP3 in brown adipose tissue mitochondria in vitro in the presence of
identical malonate/succinate conditions as in (A). Symbols: −26S (open circles): all required in vitro components minus the 26S proteasome. Closed circles: all required in vitro
components. Data represent area under the curve individual values and means±SEM. (C) Dependence of UCP3 degradation on membrane potential. Area under the curve values
from (B) plotted against the membrane potentials from (A). (D) Membrane potential over time under in vitro degradation assay conditions with the addition of TPMP. Samples
were removed at times indicated for membrane potential measurement (Section 2.6). Dotted line at 140 marks a 20 mV drop from resting membrane potential. Data represent
means±SEM (n=3). Inset: cytochrome c release from isolated mitochondria during in vitro incubation under degradation conditions plus (26S) andminus (ctl) 26S proteasome or
plus 26S proteasome and FCCP (FCCP), plotted as nmol cyt c per mg total mitochondrial protein against time. Datapoints at 0 and 120 min represent n=5 technical replicates; error
bars arewithin data symbols. (E)Membrane potential measurements 60 min after substrate addition under degradation assay conditions, plus (26S) andminus (ctl) 26S proteasome.
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mitochondrial preparation.
3.3. Ubiquitin Lys-48 is necessary and sufﬁcient for UCP3 degradation
Since ubiquitylation of proteins occurs by addition of either
monomers or polymers of ubiquitin, with linkages through one or
more of ubiquitin's seven lysine residues [15], we tested whichproperties of ubiquitin were required for successful UCP3 degradation
(Fig. 3A). Use of puriﬁed mutant ubiquitins in the in vitro assay
revealed that Ub-CH4 (which supports only mono-ubiquitylation)
was unable to support UCP3 degradation, suggesting that polyubi-
quitylation is required. Ub-K48R (lacking Lys-48) was also unable to
support UCP3 degradation, suggesting that K48-linked polyubiquitin
is necessary to support proteasomal degradation of UCP3. Further, a
ubiquitin mutant with Lys-Arg substitutions at every residue except
Fig. 6. Effect of pH on UCP3 degradation in vitro. (A) Degradation of UCP3 in brown
adipose tissue mitochondria in vitro at different pH values. Symbols: −26S (open
circles): all required in vitro components minus the 26S proteasome. Closed symbols:
all required in vitro components, varying pH. (B) Area under the curve values of the
individual experiments in (A). Data represent means±SEM (n=3–6).
Fig. 7. Requirement for the 26S proteasome in UCP3 degradation in vitro.
(A) Chymotrypsin-like peptidase cleavage of suc-LLVY-amc by puriﬁed 20S and 26S
proteasomes under degradation assay conditions. (B) Degradation of UCP3 in brown
adipose tissue mitochondria in vitro using either 20S or 26S proteasomes. Symbols:−26S
(open circles): all required in vitro components minus the 26S proteasome. 26S (closed
circles): all required in vitro components, 20S (closed triangles): 20S core proteasome.
Data represent means±SEM (n=4).
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sufﬁciency of K48 for proper degradation of UCP3 by the 26S
proteasome. Only wild-type ubiquitin and the K48O mutant could
signiﬁcantly decrease UCP3 levels (Fig. 3B). Thus, K-48 linkage of
ubiquitin is both necessary and sufﬁcient to support UCP3 degrada-
tion in vitro.3.4. UCP3 degradation requires matrix ATP
Since the assembly and activity of the 26S proteasome is ATP-
dependent [16], extramitochondrial ATP is required for proteasomal
degradation of UCP2 and UCP3 in vitro. We investigated whether ATP
is also required for intramitochondrial steps of UCP3 degradation. We
assayed degradation in the presence of carboxyatractylate (CAT),
which blocks the transport of ATP into the matrix by the adenine
nucleotide translocase, and oligomycin, which inhibits the FoF1 ATP
synthase and prevents ATP synthesis in the mitochondrial matrix.
Treatment with CAT or oligomycin alone had no effect on UCP3
degradation. Together, however, they blocked UCP3 degradation
(Fig. 4A and C). With oligomycin inhibiting ATP synthesis, matrix ATP
can still be maintained through import by the ANT. Conversely, CAT
blocks the ANT, but matrix ATP can be generated by the ATP synthase.
Thus, only with both inhibitors present is matrix ATP not maintained.
The inhibition of UCP3 degradation under these conditions demon-
strates the requirement for matrix ATP to support UCP3 degradation
by the proteasome.3.5. UCP3 degradation in vitro requires membrane potential but not a pH
gradient
In high-potassium medium, nigericin (a K+/H+ exchanger)
collapses the pH gradient across the mitochondrial membrane and
increases the membrane potential [17]. UCP3 degradation was not
obviously affected by addition of nigericin (Fig. 4B and C), suggesting
that a transmembrane pH gradient is not required. Addition of
valinomycin, which collapses the electrical potential (and, by causing
swelling, also fully dissipates the protonmotive force), prevented
UCP3 degradation. Thus, degradation of UCP3, like degradation of
UCP2 [8], appears to be independent of the pH gradient, but requires
the membrane potential component of protonmotive force.
3.6. Sensitivity of UCP3 degradation to mitochondrial membrane
potential
We investigated the dependence of UCP3degradation onmembrane
potential. Fig. 5A shows a titration of membrane potential with
malonate (a competitive inhibitor of succinate oxidation) performed
under standard degradation assay conditions. The combined concen-
tration of succinate plus malonate was kept at 20 mM. UCP3
degradation was measured under identical conditions (Fig. 5B);
degradation was not signiﬁcantly greater than the negative control
(minus 26S) when malonate made up 3% or more of the substrate
mixture. Plotting UCP3 degradation (Fig. 5B) against membrane
potential (Fig. 5A) in Fig. 5C revealed that UCP3 degradation was very
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potential dropped by 20 mV from the fully energized state. At lower
potentials UCP3 degradation appeared to decrease further, but the
degradation was not signiﬁcantly different from zero (Fig. 5B), showing
that signiﬁcant rapid UCP3 degradation requires a high potential, above
about 120 mV.
This acute sensitivity to membrane potential may explain the lack
of complete degradation in vitro of UCP3 ([9] and the present paper)
(and UCP2 [8]), sincemitochondria may not be able tomaintain a high
membrane potential when incubated at 37 °C for more than 2 h (e.g.,
Fig. 1). To examine this possibility, we incubated mitochondria under
in vitro degradation conditions minus proteasome and removed
samples at various times for measurement of membrane potential
(Fig. 5D). By 60–90 min, the membrane potential had fallen by 10–
20 mV. This likely explains why degradation of UCP3 in vitro slows or
even stops prior to completion, and suggests that the kinetics of decay
would be faster and more complete if potential was maintained than
they are in these in vitro degradation assays where the mitochondria
are not fully functional after an hour or so at 37 °C. To examine the
possibility that the 26S proteasome affects membrane potential over
time, we measured membrane potential at 60 min in the presence of
12 μg/mL puriﬁed 26S proteasome and found no differences between
samples minus and plus proteasome (Fig. 5E).
ThoughUCP3degradationkinetics are the same in cells and in vitro, it
is possible that the in vitro degradation mechanism is affected by
prolonged exposure to a hypotonic medium, allowing swelling and
perhaps breakage of the outer membrane. To test this, we assayed
mitochondrial outer membrane permeability by monitoring cyto-
chrome c release into the incubationmediumunder in vitro degradation
conditions. We found that by 60 min, the apparent time threshold of a
functioning UCP3 degradation mechanism, approximately 11% of the
total cytochrome cwas detectable in the supernatant of samples minus
and plus 26S proteasome (Fig. 5D, inset). Under identical conditions,
40–50% of UCP3 is degraded when 26S proteasome is present. Addition
of 10 μM FCCP, which abolishes both membrane potential and UCP3
degradation (experiments not shown), increased cytochrome c release,
further separating UCP3 degradation from outer membrane instability.
This demonstrates that breakage of the outer membrane is not the
underlying cause driving UCP3 degradation by exogenous 26S
proteasome.3.7. pH dependence UCP3 degradation in vitro
We tested whether changing the pH within the optimal range of
proteasome activity (pH 7–8) affected UCP3 degradation (Fig. 6A and
B). Varying the extramitochondrial pH in steps of 0.2 U revealed a
dramatic shift UCP3 degradation activity. Degradation was optimal
between pH 7.0 and 7.4, peaking at 7.2, and absent at 7.6 and above.
Since the ubiquitin hydrolase activity of the 19S regulatory particle of
the 26S proteasome has a pH optimum slightly more alkaline than
does the 20S core, this may implicate 19S regulatory particle activity
in the pathway of degradation of UCP3.3.8. Involvement of the assembled 26S proteasome in UCP3 degradation
Todifferentiate between a requirement for the 20S coreparticle anda
fully assembled 26S proteasome (including the19S regulatory particle),
we compared the abilities of the 26S proteasome and the 20S
proteasome core particle to degrade UCP3. Fig. 7A conﬁrms that both
the 20S and 26S proteasomeswere active under the in vitro degradation
assay conditions. Fig. 7B shows that only the 26S proteasome supported
UCP3 degradation. These data suggest that UCP3 degradation depends
on an intact 26S complex, including its de-ubiquitylation and protein
unfolding activities.4. Discussion
In the work presented here we identify the molecular components
(K48 ubiquitin, assembled 26S proteasome) and mitochondrial status
(matrix ATP present, mitochondrial membrane potential within
20 mV of fully energized) required for rapid UCP3 degradation in
isolated mitochondria. This in vitro approach has important advan-
tages: it allows positive conﬁrmation of the necessary components,
and permits extensive manipulation to reﬁne our understanding of
mechanisms. The results reported here suggest several potential
regulatory steps for UCP3 degradation.
We show that the presence of ubiquitin, or more speciﬁcally, K48-
linked polyubiquitin, is required for UCP3 degradation. These data
support the hypothesis that UCP3 degradation occurs through
ubiquitin-dependent targeting of UCP3 to the 26S proteasome by a
K48-linked polyubiquitin moiety. Moreover, the dispensability of
additional ubiquitylation components suggests that the necessary
machinery is already present in the isolated mitochondrial fractions
used in these experiments. These data suggest that ubiquitylation of
UCP3 (and UCP2 [8]) represents a major regulatory step in its
degradation. The inability of the 20S proteasome to support UCP3
turnover in vitro is also consistent with ubiquitin-dependent
degradation, which generally requires the fully assembled 26S
proteasome [18]. This feature potentially allows UCP3 degradation
to be controlled by the concentration of 26S complexes, which in turn
is regulated by factors including oxidative stress [19,20].
Our demonstration of the high sensitivity of UCP3 degradation to
mitochondrial membrane potential is particularly interesting and
invites speculation. A high membrane potential is required to promote
hydroxynonenal activation of mild uncoupling by UCP3 [21,22].
Together, these observations suggest that UCP3 adopts an ‘active’
conformation at high membrane potential, in which its uncoupling
function can be activated by hydroxynonenal, and it can also be tagged
for degradation by ubiquitylation. Since high protonmotive force can
also cause high mitochondrial production of reactive oxygen species
[23], this suggests a scenario inwhich transient highprotonmotive force
increases superoxide production, primes UCP3 for acute activation to
causemild uncoupling (attenuating protonmotive force and superoxide
production), and simultaneouslyprimesUCP3 for degradation so that its
activated state is rapidly destroyed by protein turnover and the system
can quickly return to its fully coupled statewhen the transient stress has
passed. In this way, UCP3 could provide, over tens of minutes, both a
short-term memory of peaks of high membrane potential, and a
transient defense against the resulting and future high oxidative stress.
A complementary function of UCP3 could be to act as an adaptor in the
mitochondrial membrane between protonmotive force and cellular
machinery. The decreased degradation of UCP3 at slightly low
membrane potential will lead to its accumulation in the membrane,
and, through interaction with other proteins, this accumulation could
report the depolarization to extramitochondrial pathways, such as
transcriptional regulation (e.g., to stimulate mitochondrial biogenesis)
or mitophagy (e.g., to degrade dysfunctional mitochondria).
The high sensitivity of UCP3 degradation to membrane potential
may also explain a feature of the in vitro assay. The membrane
potential falls enough within the ﬁrst 60 min of incubation at 37 °C
(Fig. 5D) to signiﬁcantly slow UCP3 degradation, perhaps explaining
why degradation is incomplete. If so, decay from 0 to 60 min may
most accurately model fully active UCP3 degradation in vitro, giving a
t1/2 of 30 min or less. In some cases (e.g., Fig. 4) there is further UCP3
loss after 60 min, which may indicate residual activity, or a “primed”
degradation mechanism in which initiation is potential-dependent
but subsequent steps are not.
Alternative explanations for UCP3 degradation in vitro involve
potential artifacts of the assay conditions and UCP3 detection
methods. For example, the extended mitochondrial incubation period
could alter mitochondrial integrity or activity (e.g., by swelling) in a
1481S.A. Mookerjee, M.D. Brand / Biochimica et Biophysica Acta 1807 (2011) 1474–1481way that facilitates UCP3 clearance or removal of the epitope-
containing C-terminus. However, the rapid degradation of UCP3 in
vitromatches its turnover in cell culture [9] and the turnover of UCP2
(detected at an internal epitope) in cells and in vitro [8], making a
physiological, rather than artifactual mechanism more likely. In
addition, an artifact would be more likely to affect other, similar
mitochondrial carriers. We do not observe rapid turnover of UCP1 or
ANT, suggesting a selective mechanism.
5. Conclusion and perspective
These data expand our current understanding of the mechanism
by which UCP3 (and probably UCP2) are degraded. Based on evidence
presented here, we propose that high mitochondrial membrane
potential allows initiation of degradation through a conformational
change, allowing UCP3 to be polyubiquitylated. Following its
modiﬁcation, either UCP3 or its polyubiquitin tag is exposed to the
outer mitochondrial surface. The 19S regulatory cap of the 26S
proteasome then recognizes and binds UCP3, and mediates its de-
ubiquitylation and proteasomal degradation. At least one step in this
process requires matrix ATP.
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